We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radioactive Carbon Incorporated in Urea for H. Pylori Test

By LabMedica International staff writers
Posted on 26 Nov 2008
The noninvasive test method used clinically for the diagnosis of Helicobacter pylori infection and post-eradication follow-up is the urea breath test (UBT). More...
A probe for the bacteria has been developed by incorporating a radioactive isotope of carbon into the urea used for the test.

H. pylori produce an enzyme, urease, which catalyzes the hydrolysis of the urea molecule into ammonium and carbon dioxide. The urea contains one carbon atom that is replaced by the radioactive carbon isotope. The probe, developed by Stat Diagnostics Services (Mumbai, India), is called the Heliprobe instrument.

A Helicap (hard urea 14C) is ingested with 50 ml of water. When H. pylori are present in the stomach, urease metabolizes the C-urea releasing carbon dioxide containing the C-labeled atoms. The carbon dioxide passes through the mucosa into the blood stream and it is transported to the lungs where it is exhaled. The amount of CO2 produced in the stomach can be measured with the Heliprobe instrument.

If the patient is not infected, no metabolisation of urea will occur and therefore no CO2 is detected--the unmetabolised C urea will be excreted in the urine. If the Heliprobe system detects CO2, this is diagnostic evidence of an ongoing infection with H. pylori.

Related Links:
Stat Diagnostics Services



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette
Accumax Smart Series
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.